These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25667934)

  • 1. Translationally controlled tumor protein in prostatic adenocarcinoma: correlation with tumor grading and treatment-related changes.
    Rocca BJ; Ginori A; Barone A; Calandra C; Crivelli F; De Falco G; Gazaneo S; Tripodi S; Cevenini G; del Vecchio MT; Ambrosio MR; Tosi P
    Biomed Res Int; 2015; 2015():985950. PubMed ID: 25667934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.
    del Vecchio MT; Tripodi SA; Arcuri F; Pergola L; Hako L; Vatti R; Cintorino M
    Prostate; 2000 Sep; 45(1):51-7. PubMed ID: 10960842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic Vascularization in Prostate Adenocarcinoma: Correlation with Tumor Grade, Androgen Withdrawal and Prognosis.
    Ambrosio MR; Rocca BJ; Barone A; Ginori A; Crivelli F; Pirtoli L; Del Vecchio MT
    Anticancer Res; 2015 Oct; 35(10):5595-600. PubMed ID: 26408731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers.
    Wang X; Qi M; Zhang J; Sun X; Guo H; Pang Y; Zhang Q; Chen X; Zhang R; Liu Z; Liu L; Hao X; Han B
    Prostate; 2019 May; 79(7):709-719. PubMed ID: 30825345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor expression in untreated and androgen-deprived patients with prostate cancer.
    Aslan G; Cimen S; Yorukoglu K; Tuna B; Sonmez D; Mungan U; Celebi I
    Pathol Res Pract; 2005; 201(8-9):593-8. PubMed ID: 16259113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma.
    Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H
    Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Aquaporin-1 is a Prognostic Factor for Biochemical Recurrence in Prostate Adenocarcinoma.
    Park JY; Yoon G
    Pathol Oncol Res; 2017 Jan; 23(1):189-196. PubMed ID: 27817002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer.
    Imasato Y; Xuan JW; Sakai H; Izawa JI; Saito Y; Chin JL; Moussa M
    J Urol; 2000 Nov; 164(5):1819-24. PubMed ID: 11025776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.
    Van der Kwast TH; Têtu B; Fradet Y; Dupont A; Gomez J; Cusan L; Diamond P; Labrie F
    Prostate; 1996 Apr; 28(4):227-31. PubMed ID: 8602398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of RhoC and ZAG protein expression as biomarkers for prediction of PSA failure following radical prostatectomy for high grade prostate cancer.
    Mills J; Oliver A; Sherwin JC; Frydenberg M; Peters JS; Costello A; Harewood L; Love C; Redgrave N; van Golen KL; Bailey M; Pedersen J
    Pathology; 2012 Oct; 44(6):513-8. PubMed ID: 22935975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF Beta1 Expression Correlates with Survival and Tumor Aggressiveness of Prostate Cancer.
    Wu CT; Chang YH; Lin WY; Chen WC; Chen MF
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1587-93. PubMed ID: 26271396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
    Kim WY; Whang YE; Pruthi RS; Baggstrom MQ; Rathmell WK; Rosenman JG; Wallen EM; Goyal LK; Grigson G; Watkins C; Godley PA
    Urol Oncol; 2011; 29(6):608-13. PubMed ID: 20022268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of androgen receptor in prostatic neoplasia versus hyperplasia.
    Husain I; Shukla S; Soni P; Husain N
    J Cancer Res Ther; 2016; 12(1):112-6. PubMed ID: 27072221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
    Rabien A; Fritzsche FR; Jung M; Tölle A; Diamandis EP; Miller K; Jung K; Kristiansen G; Stephan C
    Int J Cancer; 2010 Nov; 127(10):2386-94. PubMed ID: 20473923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of plasma intermedin levels with progression and metastasis in men after radical prostatectomy for localized prostatic cancer.
    Wang XL; Wang YY; He HD; Xie X; Yu ZJ; Pan YM
    Cancer Biomark; 2015; 15(6):799-805. PubMed ID: 26406405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma.
    Claudio PP; Zamparelli A; Garcia FU; Claudio L; Ammirati G; Farina A; Bovicelli A; Russo G; Giordano GG; McGinnis DE; Giordano A; Cardi G
    Clin Cancer Res; 2002 Jun; 8(6):1808-15. PubMed ID: 12060621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.
    Lee SW; Cho JM; Cho HJ; Kang JY; Kim EK; Yoo TK
    Korean J Urol; 2015 Jul; 56(7):505-14. PubMed ID: 26175869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.